Related Experiment Videos

MR imaging of minamata disease: qualitative and quantitative analysis

Y Korogi1, M Takahashi, M Sumi

  • 1Department of Radiology, Kumamoto University School of Medicine, Japan.

Radiation Medicine
|September 1, 1994
PubMed

Insights

Minamata disease, a neurological disorder from methylmercury poisoning, shows specific brain atrophy in MRI scans. This imaging helps identify central nervous system damage linked to the disease's symptoms.

Area of Science:

  • Neurology
  • Radiology
  • Toxicology

Background:

  • Minamata disease (MD) is a severe neurological disorder caused by methylmercury poisoning through contaminated seafood.
  • Key symptoms include sensory disturbance, visual field constriction, and ataxia.

Purpose of the Study:

  • To evaluate Magnetic Resonance (MR) imaging findings in patients with Minamata disease.
  • To quantitatively and qualitatively assess central nervous system (CNS) abnormalities in MD patients.

Main Methods:

  • MR imaging was performed on seven MD patients and eight healthy controls using a 1.5 Tesla scanner.
  • Quantitative image analysis focused on specific brain regions, including the cerebellum, cerebral hemispheres, and brainstem.

Main Results:

  • Significant atrophy was observed in the cerebellar vermis and hemispheres of MD patients compared to controls.
  • Dilated calcarine and central sulci indicated atrophy in the visual and postcentral cortex, respectively.
  • No significant differences were found in the basis pontis, middle cerebellar peduncles, corpus callosum, or cerebral hemispheres.

Conclusions:

  • MR imaging is effective in detecting CNS abnormalities associated with methylmercury poisoning.
  • Specific brain regions like the cerebellum and visual cortex show atrophy correlating with MD symptoms.
  • Quantitative MRI analysis provides valuable insights into the neurological damage caused by Minamata disease.

Related Concept Videos